Upload Avatar (500 x 500)
Yanyan Jiang
Pharmaceutical Sciences
Fudan University
Shanghai
Language: Chinese, English
Nanotechnology
Drug Targeting
Delivery Systems
New Drug Formulations
Preparations
Tumor Targeting
Nanoparticles
Biopharmaceutics
Pharmaceutical Research
Drug Development
Areas of Focus
- Nanotechnology-based drug targeting and delivery systems
- Research and development of new drug formulations and preparations
Work Experience
- 1990.07 – 1992.05 Kunming Yan'an Hospital, Department of Pharmacy, Pharmacist
- 1992.05 – 1996.08 Harbin Fifth Hospital, Department of Pharmacy, Pharmacist
- 1999.07 – Present Fudan University School of Pharmacy, Lecturer, Associate Professor, Professor
Academic Background & Achievements
- 1986.09 – 1990.06 Bachelor in Pharmaceutics: Shenyang Pharmaceutical University
- 1996.09 – 1999.06 Master in Pharmaceutics: Shenyang Pharmaceutical University
- 2001.09 – 2005.06 PhD in Pharmaceutics: Fudan University
Publications
- Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy, XF Zhang, S Yao, C Liu, YY Jiang, 2015
- Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates, K Wang, XF Zhang, Y Liu, C Liu, BH Jiang, YY Jiang, 2014
- Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release, K Wang, XF Zhang, LH Zhang, LL Qian, C Liu, JJ Zheng, YY Jiang, 2015
- Cationic core-shell nanoparticles with carmustine contained within O6-benzylguanine shell for glioma therapy, LL Qian, JJ Zheng, K Wang, Y Tang, XF Zhang, HS Zhang, FP Huang, YY Pei, YY Jiang, 2013
- RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular cells and tumor cells, SJ Zhu, LL Qian, MH Hong, LH Zhang, YY Pei, YY Jiang, 2011
- RGD-modified PEG-PAMAM-DOX Conjugates: In vitro and In vivo Studies for Glioma, Lihong Zhang, Saijie Zhu, Lili Qian, Yuanying Pei, Yongming Qiu, Yanyan Jiang, 2011
- Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style, SJ Zhu, MH Hong, GT Tang, LL Qian, JY Lin, YY Jiang, YY Pei, 2010
- PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In vitro Evaluation, and In vivo Tumor Accumulation, SJ Zhu, MH Hong, LH Zhang, GT Tang, YY Jiang, YY Pei, 2010
- PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and non-covalent drug inclusion complex, YY Jiang, GT Tang, SY Kong, SJ Zhu, YY Pei, 2010
- Tumor cell targeting of transferrin-PEG-TNF-α conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation, Yan-Yan Jiang, Chen Liu, Ming-Huang Hong, Sai-Jie Zhu, and Yuan-Ying Pei, 2007
